Pirfenidone Tablet, Coated
Product Images NDC 46708-480

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 46708-480). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pirfenidone Figure1)

The text describes a chart or graph presenting data on the percentage of patients experiencing worsening or no decline in %FVC (forced vital capacity) over a 52-week period. The chart is divided into categories of %FVC decline, ranging from 10% to 90+%. Two groups, Pirfenidone and Placebo, are being compared, with the number of participants in each group (278 and 277, respectively) noted. The only available data point shown in the chart is the absolute change in %FVC from baseline to week 52, which is labeled as a 10% increase.*

FDA Label Image

Figure 2 (Pirfenidone Figure2)

FDA Label Image

Figure 3 (Pirfenidone Figure3)

This is a graph showing the percentage of patients who are alive over time for two groups, Pirfenidone (n=623) and Placebo (n=624). The hazard ratio (HR) with a 95% confidence interval (Cl) is also provided.*

FDA Label Image

500 Tablets (Pirfenidone mg 267)

FDA Label Image

500 Tablets (Pirfenidone mg 801)

FDA Label Image

Pirfenidone (Pirfenidone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.